The Net Margin of FibroGen Inc (FGEN) is
-160.63%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date |
Value |
| 2024-12-31 |
-160.63%
|
| 2023-12-31 |
-192.37%
|
| 2022-12-31 |
-208.74%
|
| 2021-12-31 |
-123.25%
|
| 2020-12-31 |
-107.37%
|
| 2019-12-31 |
-30.01%
|
| 2018-12-31 |
-40.56%
|
| 2017-12-31 |
-92.29%
|
| 2016-12-31 |
-31.71%
|
| 2015-12-31 |
-47.46%
|
| Ticker |
Name |
Value |
|
950160.KQ
|
Kolon TissueGene Inc
|
-3733.25%
|
|
ABBV
|
AbbVie Inc.
|
6.91%
|
|
BLUE
|
Genetix Biotherapeutics Inc
|
-287.23%
|
|
FOLD
|
Amicus Therapeutics Inc
|
-4.27%
|
|
MCRB
|
Seres Therapeutics, Inc.
|
721.93%
|
|
APLS
|
Apellis Pharmaceuticals, Inc.
|
2.23%
|
|
DCPH
|
Deciphera Pharmaceuticals Inc
|
-119.34%
|
|
LEGN
|
Legend Biotech Corporation
|
-28.85%
|
|
MYOV
|
Myovant Sciences Ltd
|
-89.18%
|
|
DRNA
|
Dicerna Pharmaceuticals Inc
|
-68.59%
|
|
IMCR
|
Immunocore Holdings PLC
|
-8.88%
|
|
MRNA
|
Moderna, Inc.
|
-145.16%
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
31.41%
|
|
SGMO
|
Sangamo Therapeutics Inc
|
-310.81%
|
|
950220.KQ
|
Neoimmunetech Inc
|
-33533.01%
|
|
ALXO
|
ALX Oncology Holdings Inc
|
-3876.27%
|
|
IGMS
|
IGM Biosciences LLC
|
-7316.16%
|
|
KYMR
|
Kymera Therapeutics, Inc.
|
-794.04%
|
|
RCUS
|
Arcus Biosciences, Inc.
|
-142.91%
|
|
BCAB
|
Bioatla Inc
|
-2980.35%
|
|
CCXI
|
Churchill Capital Corp XI
|
-408.87%
|
|
INO
|
Inovio Pharmaceuticals Inc
|
-130005.97%
|
|
LGND
|
Ligand Pharmaceuticals Incorporated
|
46.42%
|
|
RVMD
|
Revolution Medicines, Inc.
|
-3768.28%
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
32.94%
|
|
ADCT
|
Adc Therapeutics Ltd
|
-175.31%
|
|
RLAY
|
Relay Therapeutics, Inc.
|
-1800.58%
|
|
VIE
|
Viela Bio Inc
|
-1293.07%
|
|
950200.KQ
|
Psomagen Inc
|
-5.04%
|
|
AMGN
|
Amgen Inc
|
20.98%
|
|
GILD
|
Gilead Sciences, Inc.
|
28.90%
|
|
SWTX
|
SpringWorks Therapeutics, Inc.
|
-134.73%
|
|
GBT
|
Global Blood Therapeutics Inc
|
-155.63%
|
|
PRLD
|
Prelude Therapeutics Incorporated
|
-819.59%
|